Ionis Pharmaceuticals Inc (ISI)

  • Volume:
  • Bid/Ask:
  • Day's Range:
    26.660 - 26.660
  • Type:Equity
  • Market:Germany
  • ISIN:US4622221004

ISI Comments

What is your sentiment on Ionis Pharmaceuticals Inc?
Vote to see community's results!

All Comments

  • What’s about this stock? Any new therapies are coming out?
    • I think shareholders needs a therapy now. BIIB / IONIS Tofersen (BIIB067) Phase 3 test did unsuccesful
  • Absolutely underrated stock. See you in ten years or this fall when the product in cooperation with Biogen comes out
    • Added 4000 at 34.4
      • nice after market move!
        • Give the anti-corona spray from marinomed-biotech some VC and invest in a pharma company which is heading to the moon: are proving that the patented method of marinomed prevents infection with all Corona varietis including mutants. It also prevents other virus infections. They have many patents.  Do some good and get rich
          • CARLSBAD, Calif., March 22, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced its partner, Roche, has decided to discontinue dosing in the Phase III GENERATION HD1 study of tominersen in manifest Huntington's disease (HD). The decision was based on the results of a pre-planned review of data from the Phase III study conducted by an unblinded Independent Data Monitoring Committee (iDMC). While there were no new or emerging safety signals identified for tominersen, the iDMC made its recommendation based on the investigational therapy's potential benefit/risk profile for study participants. Participants will continue to be followed for safety and clinical outcomes.
            • this stock doesn't know what a green day looks like.
              • ㅜㅜ~

                7 eBooks for free

                A great tool for anyone who wants to learn to trade the financial markets. Whether a novice trader or an experienced trader.

                Currency Explorer

                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.